Free Trial

ICU Medical (ICUI) Competitors

ICU Medical logo
$160.32 +3.14 (+2.00%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$160.26 -0.06 (-0.03%)
As of 10/9/2026 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICUI vs. SOLV, COO, ALGN, BLCO, and MMSI

Should you buy ICU Medical stock or one of its competitors? ICU Medical's main competitors and comparable companies include Solventum (SOLV), Cooper Companies (COO), Align Technology (ALGN), Bausch + Lomb (BLCO), and Merit Medical Systems (MMSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does ICU Medical compare to Solventum?

ICU Medical (NASDAQ:ICUI) and Solventum (NYSE:SOLV) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

ICU Medical currently has a consensus target price of $192.80, suggesting a potential upside of 20.26%. Solventum has a consensus target price of $92.80, suggesting a potential upside of 6.04%. Given ICU Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe ICU Medical is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Solventum
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64

In the previous week, Solventum had 3 more articles in the media than ICU Medical. MarketBeat recorded 6 mentions for Solventum and 3 mentions for ICU Medical. Solventum's average media sentiment score of 0.84 beat ICU Medical's score of 0.51 indicating that Solventum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

96.1% of ICU Medical shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 0.2% of Solventum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ICU Medical has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Solventum has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

Solventum has higher revenue and earnings than ICU Medical. Solventum is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.80$730K$1.18135.86
Solventum$8.33B1.79$1.56B$8.1810.70

Solventum has a net margin of 17.26% compared to ICU Medical's net margin of 1.39%. Solventum's return on equity of 25.09% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Solventum 17.26%25.09%8.78%

Summary

Solventum beats ICU Medical on 9 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Cooper Companies?

ICU Medical (NASDAQ:ICUI) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

ICU Medical has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

In the previous week, Cooper Companies had 23 more articles in the media than ICU Medical. MarketBeat recorded 26 mentions for Cooper Companies and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.51 beat Cooper Companies' score of 0.10 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
5 Very Positive mention(s)
5 Positive mention(s)
10 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral

ICU Medical presently has a consensus price target of $192.80, suggesting a potential upside of 20.26%. Cooper Companies has a consensus price target of $68.60, suggesting a potential upside of 26.17%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.80$730K$1.18135.86
Cooper Companies$4.09B2.53$374.90M$2.9318.56

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cooper Companies has a net margin of 13.46% compared to ICU Medical's net margin of 1.39%. Cooper Companies' return on equity of 10.90% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Cooper Companies 13.46%10.90%7.24%

Summary

Cooper Companies beats ICU Medical on 9 of the 16 factors compared between the two stocks.

How does ICU Medical compare to Align Technology?

ICU Medical (NASDAQ:ICUI) and Align Technology (NASDAQ:ALGN) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Align Technology has higher revenue and earnings than ICU Medical. Align Technology is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.80$730K$1.18135.86
Align Technology$4.03B2.53$410.35M$5.7524.82

Align Technology has a net margin of 9.99% compared to ICU Medical's net margin of 1.39%. Align Technology's return on equity of 15.86% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Align Technology 9.99%15.86%10.32%

ICU Medical currently has a consensus target price of $192.80, indicating a potential upside of 20.26%. Align Technology has a consensus target price of $199.21, indicating a potential upside of 39.59%. Given Align Technology's higher possible upside, analysts clearly believe Align Technology is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Align Technology
0 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.63

ICU Medical has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

In the previous week, Align Technology had 9 more articles in the media than ICU Medical. MarketBeat recorded 12 mentions for Align Technology and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.51 beat Align Technology's score of 0.45 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Align Technology beats ICU Medical on 11 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Bausch + Lomb presently has a consensus price target of $19.46, indicating a potential upside of 12.21%. ICU Medical has a consensus price target of $192.80, indicating a potential upside of 20.26%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts clearly believe ICU Medical is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89

ICU Medical has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.10B1.22-$360M-$0.48N/A
ICU Medical$2.23B1.80$730K$1.18135.86

In the previous week, Bausch + Lomb had 10 more articles in the media than ICU Medical. MarketBeat recorded 13 mentions for Bausch + Lomb and 3 mentions for ICU Medical. ICU Medical's average media sentiment score of 0.51 beat Bausch + Lomb's score of 0.21 indicating that ICU Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
1 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bausch + Lomb has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

ICU Medical has a net margin of 1.39% compared to Bausch + Lomb's net margin of -3.21%. ICU Medical's return on equity of 7.91% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-3.21% 4.14% 1.93%
ICU Medical 1.39%7.91%4.17%

Summary

ICU Medical beats Bausch + Lomb on 14 of the 17 factors compared between the two stocks.

How does ICU Medical compare to Merit Medical Systems?

ICU Medical (NASDAQ:ICUI) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

Merit Medical Systems has lower revenue, but higher earnings than ICU Medical. Merit Medical Systems is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.23B1.80$730K$1.18135.86
Merit Medical Systems$1.52B3.44$128.49M$2.4236.04

ICU Medical has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to ICU Medical's net margin of 1.39%. Merit Medical Systems' return on equity of 13.75% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical1.39% 7.91% 4.17%
Merit Medical Systems 9.22%13.75%8.10%

ICU Medical currently has a consensus target price of $192.80, indicating a potential upside of 20.26%. Merit Medical Systems has a consensus target price of $100.00, indicating a potential upside of 14.67%. Given ICU Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe ICU Medical is more favorable than Merit Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
2 Strong Buy rating(s)
2.89
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83

In the previous week, ICU Medical and ICU Medical both had 3 articles in the media. ICU Medical's average media sentiment score of 0.51 beat Merit Medical Systems' score of 0.48 indicating that ICU Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Merit Medical Systems
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.1% of ICU Medical shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 2.1% of ICU Medical shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

ICU Medical and Merit Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

Get ICU Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICUI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICUI vs. The Competition

MetricICU MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.93B$5.43B$7.16B$13.21B
Dividend YieldN/A1.77%2.53%16.37%
P/E Ratio135.8625.57275.3026.16
Price / Sales1.8683.34635.97107.50
Price / Cash10.7831.8776.3853.09
Price / Book1.865.9511.226.33
Net Income$730K$146.18M$3.50B$382.15M
7 Day Performance0.59%-0.28%-0.89%-1.40%
1 Month Performance1.95%-1.88%-4.42%-3.47%
1 Year Performance40.47%5.45%7.03%1.18%

ICU Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICUI
ICU Medical
3.769 of 5 stars
$160.32
+2.0%
$192.80
+20.3%
+37.2%$3.93B$2.16B135.8613,000
SOLV
Solventum
2.1154 of 5 stars
$87.55
-0.5%
$92.80
+6.0%
+22.0%$14.90B$8.31B10.7020,000
COO
Cooper Companies
4.7605 of 5 stars
$55.70
-1.9%
$71.47
+28.3%
-22.1%$10.61B$4.24B19.0515,000
ALGN
Align Technology
3.9755 of 5 stars
$143.09
+1.7%
$201.71
+41.0%
+8.2%$10.25B$4.14B24.9020,290
BLCO
Bausch + Lomb
4.1692 of 5 stars
$17.04
-0.8%
$19.15
+12.4%
+20.2%$6.09B$5.10BN/A13,000

Related Companies and Tools


This page (NASDAQ:ICUI) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners